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True Lumen
(n¼154
lesions)
Subintimal
Stenting{
(n¼19 lesions) p value
Qualitative Findings:
Subintimal GW tracking, n (%)* 33(21.1) 19 (100) <0.001
Dissection Flap, n (%) 64 (41.6) 16 (84.2) <0.001
Dissected segment location
Proximal, n (%) 27 (17.5) 9 (47.4)
Distal, n (%) 24 (15.6) 5 (26.3) 0.003
Body, n (%) 13 (8.4) 2 (10.5)
Coronary Hematoma, n (%) 17 (11) 6 (32) 0.01
Calciﬁcation (>30o arc), n (%) 141 (92) 16 (84) 0.29
Calciﬁcation morphology
Superﬁcial, n (%) 98 (64) 7 (37) 0.02
Deep, n (%) 43 (28) 9 (47) 0.08
Quantitative Findings:
Dissection length, mm 5.4 (4 to 9) 4.2 (3 to 8.5) 0.27
Maximum arc of calcium,o 274  132 150  106 0.68
Proximal reference EEM CSA, mm2 15.7  4.4 14.4  3.6 0.2
Proximal reference lumen CSA, mm2 9.7  2.9 8.2  2.3 0.03
Distal reference EEM CSA, mm2 8.2  3.3 7.2  2.2 0.08
Distal reference lumen CSA, mm2 5.3  2 5.1  2 0.74
Post-Stent IVUS measurements:
Mean stent CSA, mm2 6.9  1.9 6.7  2.3 0.71
Stent Expansion 0.87  0.32 0.92  0.30 0.55
Stent symmetry index 0.89  0.02 0.92  0.086 0.23
Values are mean  SD, median (interquartile range), or n (%).
CSA indicates cross-sectional area; EEM, external elastic membrane; IVUS, intravascular
ultrasound.* immediately after wiring or after pre-dilation with a 1 to 2.0-mm balloon.{ ﬁnal
guidewire position in a false lumen with subsequent stent deployment in subintimal space.
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associated with procedural success and procedural complications.
Results: During the study period, CTO PCI represented 3.8% of the total PCI volume
for stable coronary artery disease (22,365 of 594,510). Overall, patients undergoing
CTO PCI required higher contrast volume and ﬂuoroscopy time and had lower
procedural success (59% vs. 96%, P< 0.001) and higher MACE rate (1.6% vs. 0.8%,
P< 0.001) than non CTO patients. On multivariable analysis, several parameters
(including older age, current smoking, prior MI, prior CABG, prior peripheral arterial
disease, prior cardiac arrest, right coronary artery CTO target vessel, and less operator
experience), were associated with lower likelihood of CTO PCI procedural success,
while operators’ annual CTO PCI volume was associated with improved success
without signiﬁcant increase in major complications.
Conclusions: CTO PCI is currently performed infrequently in the US for stable
coronary artery disease and is associated with lower procedural success and higher
complication rates compared with non-CTO PCI. Procedural success was associated
with several patient factors and operator experience.
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Long-term follow up after antegrade versus retrograde recanalization of chronic
total coronary occlusions
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Background: The recanalization success rate of chronic total coronary occlusions
(CTO-PCI) can be increased by a retrograde approach. The impact of the retrograde
compared to the antegrade PCI on long-term outcome is unknown. Aim of the study
was to evaluate the long-term MACCE rate (death, myocardial infarction, coronary
bypass surgery and stroke) in patients after retrograde versus antegrade CTO-PCI.
Methods: In a prospective study from January 2008 to June 2012 436 consecutive
patients with CTO’s ( 3 months old) were enrolled.
Results:Mean age was 63.4  10.3 years, 86% were male. The retrograde PCI, which
was used only after a failed antegrade intervention, was performed in 18 % (n¼79) of
patients. Patients with retrograde CTO-PCI had more frequently previous bypass
surgery, RCA as target vessel (79.7% vs. 56%.8, p< 0.0004), longer lesion length (46
vs. 30 mm, p< 0.001), longer procedure duration (108.2 vs. 63.2 min, p< 0.0001),
higher contrast volume (433.6 vs. 267.6 ml, p< 0.0001), longer ﬂuoroscopy time
(61.2 vs 30.1 min, p< 0.0001) and higher radiation exposure (285.3 vs. 145,0
Gycm2m p< 0.0001). Long-term overall MACCE rate (mean follow up 590  461
days) was not different after retrograde vs. antegrade CTO-PCI (14.3% vs. 15.1 %).
Same was true for the components of MACCE (death 5.7 vs. 8.5%, myocardial
infarction 2.8 vs. 2.6%, bypass surgery 8.6 vs. 5.3%, stroke 0 vs. 2.6%). However,
patients with failed antegrade PCI had a signiﬁcantly higher long-term MACCE rate
compared to successful antegrade PCI (29.2 vs. 12.5%, p< 0.04), whereas the MACCE
rate of failed vs. successful retrograde PCI was not different (14.3 vs. 14.3%).
Conclusions: Despite more patients with previous coronary bypass surgery and more
complex target lesions and procedures the overall long-term MACCE rate after
retrograde CTO-PCI is not different to antegrade CTO-PCI. Why the long-term
MACCE rate is higher only after failed vs. successful antegrade but not after failed vs.
successful retrograde CTO-PCI deserves further studies.
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Background: We evaluated the in-hospital and the long-term clinical and angio-
graphic outcomes of drug-eluting stents (DES) deployed in true versus false lumen of
successfully crossed chronic total occlusions (CTO)
Methods: Between August 2011 and October 2012, 157 consecutive patients with
173 CTO lesions were successfully recanalized in a single center. All procedures were
guided with intravascular ultrasound (IVUS). After successful guidewire crossing,
lesions were classiﬁed according to IVUS evaluation into 2 groups; (1) true lumen
group and, (2) subintimal stenting group; and compared with regards to in-hospital
and long term clinical outcomes
Results: In 154 lesions, DES were deployed in the true lumen; and in 19 (11%) le-
sions, DES were deployed in the subintimal space (95% conﬁdence interval: 6.3% to
15.6%) with a success rate of 96 % and 82.4%, in antegrade and retrograde ap-
proaches, respectively. IVUS showed that the prevalence of dissection was two times
and intramural hematoma (IMH) was three times as higher in the subintimal stenting
group (p< 0.001 and p< 0.01, respectively).Subintimal stenting was associated with a
signiﬁcant increase in minor perforations 6/19 (31.6 % vs. 8.4%, p¼0.002), all were
managed conservatively. Kaplan-Meier analysis revealed a similar rates of binary
restenosis and target lesion revascularization between groups (p¼0.73 and p¼0.97,
respectively).Six patients (4.6%, 6 / 129 patients) in the true lumen group and none in
the subintimal group died at one yearJACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/CoIVUS FindingsConclusions: Subintimal stent deployment in CTO segments, using second generation
DES with IVUS guidance, carries a similar success rate and long-term angiographic
and clinical outcomes as true lumen stenting
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Background: Transradial access is often used in percutaneous coronary inter-
vention(PCI) for chronic total occlusions (CTO), however, its efﬁcacy and safety in
this setting have received limited study.
Methods: We compared the technique and outcomes of transradial vs. transfemoral
access among 650 CTO PCI cases performed between January 2012 and March 2014
at 6 US centers.
Results: Most patients were men (87%) with high frequency of diabetes mellitus
(42%) and prior coronary artery bypass graft surgery (36%). The CTO target vessel
was the right coronary (59%), left anterior descending (20%), or circumﬂex (17%)
artery. TR access was used in 110 (17%) of the 650 cases, as follows: bilateral radial
access (63%); bilateral radial access plus unilateral or bilateral femoral access (7%);
unilateral radial access plus unilateral or bilateral femoral access (26%); and unilateral
radial access (4%). Six and eight French guide catheters were used through the radial
and femoral artery, respectively. Compared to transfemoral, transradial cases had
similar technical (92.6% vs. 93.0%, p¼0.87) and procedural (91.1% vs. 90.0%,
p¼0.95) success and major complication rates (1.7% vs 1.8 %, p¼0.99). However,
transradial access was associated with higher mean procedure (14283 vs. 12060
min, p¼0.008) and ﬂuoroscopy (5840 vs. 4931 min, p< 0.026) time, and number
of crossing approach changes (0.71.0 vs. 0.50.7, p¼0.008).ronary Lesions - CTO B57
Table. Clinical outcomes in all study patients
Medication Revascularization
Unadjusted
HR (95% CI)
p
Value
3Adjusted HR(95%
CI)
p
Value
Total population
(n¼738)
n¼236 n¼502
All-cause death 44 (18.6) 39 (7.8) 0.39 (0.26-0.61) <0.01 0.44 (0.27-0.71) <0.01
Cardiac death 23 (9.7) 17 (3.4) 0.33 (0.18-0.61) <0.01 0.29 (0.15-0.58) <0.01
MI 2 (0.8) 4 (0.8) 0.91 (0.17-4.98) 0.92 1.04 (0.16-6.80) 0.97
1Repeat
revascularization
37 (15.7) 34 (6.8) 0.38 (0.24-0.61) <0.01 0.38 (0.23-0.63) <0.01
2MACE 59 (25.0) 51 (10.2) 0.36 (0.25-0.52) <0.01 0.32 (0.21-0.49) <0.01
Data are presented as n (%).
1Repeat revascularization included target vessel revascularization-PCI, non-target vessel
SATURDAY, SEPTEMBER 13, 2014, 5:00 PM–7:00 PM www.jacctctabstracts2014.comConclusions: Transradial CTO PCI can be performed with similar success and
complication rates with transfemoral CTO PCI, but is associated with longer proce-
dural and ﬂuoroscopy times.
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Background: Patients with coronary artery disease with a chronic total occlusion (CTO)
are associated with worse clinical outcome compared to patients without a CTO.
Percutaneous coronary intervention (PCI) of CTOs may have a beneﬁcial effect on
survival. In literature mainly small, observational and predominantly single center studies
exist about successful PCI and the impact on reducing long-term mortality for CTO.
Methods: This meta-analysis compared the long-term mortality of successful versus
failed PCI for CTO. Relevant studies were examined and analyzed independently by
two investigators. To prevent distortion of the results by the inclusion of (sub-)acute
100% occlusions, a subgroup analysis was performed on only those studies which
included patients with a CTO of at least 3 months.
Results: We identiﬁed 27 studies eligible for inclusion in this meta-analysis, including
11,085 CTO patients with successful and 4,347 CTO patients with unsuccessful revas-
cularization (mean follow-up duration 1 to 10 years). We did not ﬁnd any randomized
controlled trials between CTO PCI versus medical treatment only. Successful CTO PCI
was associated with reduced mortality in comparison to failed CTO PCI (odds ratio
(OR): 0.52, 95%CI: 0.43-0.62,p-value¼ 0.01). For the subgroup analyses the results
remained qualitatively similar (OR: 0.47, 95%CI: 0.35-0.64, p-value < 0.01) (ﬁgure 1).
Conclusions: This meta-analysis conﬁrmed previous ﬁndings of a reduced mortality
after successful versus failed CTO PCI. Randomized controlled trials are needed to
conﬁrm the value of PCI in patients with a CTO in reducing the mortality.revascularization-PCI and coronary artery bypass grafting (CABG).
2Major adverse cardiac events (MACE) included cardiac death, MI, and repeat revasculariza-
tion with PCI or CABG.
3Adjusted covariates include age, ACS, CTO of LAD, multiple CTOs, previous PCI and Proximal
to mid CTO
ACS ¼ acute coronary syndrome; CI ¼ conﬁdence interval; CTO ¼ coronary chronic total oc-
clusion; HR ¼ hazard ratio; LAD ¼ left anterior descending artery; MI ¼ myocardial infarction;
PCI ¼ percutaneous coronary interventionTCT-197
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Therapy in Patients with Coronary Chronic Total Occlusion and Well-developed
Collateral Circulation
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Background: Little is known about the clinical outcomes and optimal treatment
strategies of chronic total occlusion (CTO) with well-developed collateral circulation.B58 JACC Vol 64/11/Suppl BMethods: We screened 2,024 consecutive patients with at least one CTO detected on
coronary angiogram. Of these, we analyzed data from 738 patients with Rentrop 3
grade collateral circulation who were treated with medical therapy alone (n¼236),
coronary artery bypass grafting (n¼170) or percutaneous coronary intervention (PCI)
(n¼332; 80.1% successful). Patients who underwent revascularization and medical
therapy (revascularization group, n ¼502) were compared to those who underwent
medical therapy alone (medication group, n¼236) in terms of cardiac death and major
adverse cardiac events (MACE), deﬁned as the composite of cardiac death, myocar-
dial infarction, or repeat revascularization.
Results: During a median follow-up duration of 42 months, multivariate analysis
revealed a signiﬁcantly lower incidence of cardiac death (hazard ratio [HR] 0.29; 95%
conﬁdence interval [CI] 0.15 to 0.58; p< 0.01) and MACE (HR 0.32; 95% CI 0.21 to
0.49; p< 0.01) in the revascularization group compared to the medication group. After
propensity score matching, the incidence of cardiac death (HR 0.27; 95% CI 0.09 to
0.80; p¼0.02) and MACE (HR 0.44; 95% CI 0.23 to 0.82; p¼0.01) were still
signiﬁcantly lower in the revascularization group than in the medication group.Conclusions: In patients with coronary CTO and well-developed collateral circula-
tion, aggressive revascularization may reduce the risk of cardiac mortality and MACE.
These ﬁndings need to be conﬁrmed in randomized controlled trials.
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Background: The aim of this study was to describe the ﬁve-year European experience
of retrograde percutaneous coronary interventions (PCI) revascularization for complex
chronic total occlusions (CTOs) of coronary arteries.
Methods: Demographic data, procedural outcomes and in-hospital clinical events
were collected on 1582 consecutive lesions of 1395 patients enrolled between January
2008 and December 2012 having retrograde CTO PCI at 44 European medical centers
by 45 experienced interventionalist operators. A retrograde J-CTO score was used to
better describe success according to lesion difﬁculty. Data about clinical follow-up
were collected.
Results: Patients mean age was 62.0  10.4 years. During the procedure the retro-
grade approach was used as ﬁrst line strategy in 76.2% of cases, while immediately
after antegrade failed approach in 23.8% of cases. Procedural success was achieved
in 75.3% of cases. A major complication occurred in 16 patients (1.0%). In multi-
variable analysis, age of the patient (per 10-year increase) (OR:1.19, 95%CI:1.03-
1.34; p¼0.02), lower operator volume (OR:3.00, 95%CI:2.41-4.21; p< 0.001) and
increased retrograde J-CTO score (OR:0.42, 95%CI:0.24-0.74; p< 0.001) were
recognized as independent predictors of procedural failure. The mean follow-up
period was 24.7  15.0 months. Major adverse cardiac and cerebral events
(MACCE) occurred in 13.6% of cases (cardiac death 1.9%, myocardial infarction
3.2%, stroke 0.6% and target vessel revascularization 13%). By multivariate Cox
regression, the independent predictors of MACCE were: male gender (HR:0.47, 95%
CI:0.30-0.74; p¼0.01); prior myocardial infarction (HR:1.45, 95%CI:1.01-2.09;
p¼0.04); number of previous attempts (HR:1.63, 95%CI:1.36-1.95; p< 0.001); CTO
length (HR:1.01, 95%CI:1.00-1.02; p¼0.004); and total stent length (HR:0.98, 95%
CI:0.97-0.98;p< 0.001).
Conclusions: In Europe among selected centers dedicated to CTO revascularization,
retrograde approach was performed over a 5-year period in 16.5% of these patients.j September 13–17, 2014 j TCT Abstracts/Coronary Lesions - CTO
